|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 74.50 EUR | +0.15% |
|
-6.78% | -9.94% |
| 03:18am | US FDA approves first mRNA flu shot from Moderna | RE |
| 08-04 | European Stocks Close Higher Tuesday on Earnings Strength, Hormuz Talks | MT |
| Market Cap | 89.26B 103B 83.2B 76.52B 144B 9,799B 146B 978B 384B 4,903B 387B 379B 16,238B | P/E 2026 * |
12.2x | P/E 2027 * | 10.3x |
|---|---|---|---|---|---|
| Enterprise Value | 101B 116B 93.8B 86.27B 163B 11,047B 165B 1,102B 433B 5,527B 436B 427B 18,306B | EV / Sales 2026 * |
2.12x | EV / Sales 2027 * | 1.91x |
| Free-Float |
88.48% | Yield 2026 * |
5.69% | Yield 2027 * | 6.04% |
Last Transcript: Sanofi
| 1 day | +0.15% | ||
| 1 week | -6.78% | ||
| Current month | +0.04% | ||
| 1 month | -1.73% | ||
| 3 months | +0.46% | ||
| 6 months | -8.13% | ||
| Current year | -9.94% |
| 1 week | 73.72 |  | 75.89 |
| 1 month | 72.07 | | 80.18 |
| Current year | 71.25 | | 84.97 |
| 1 year | 71.25 | | 91.15 |
| 3 years | 71.25 | | 110.88 |
| 5 years | 71.25 | | 110.88 |
| 10 years | 62.88 | | 110.88 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 65 | 30/04/2026 | |
| Director of Finance/CFO | 64 | 31/03/2024 | |
Houman Ashrafian
CTO | Chief Tech/Sci/R&D Officer | 51 | 10/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 60 | 29/04/2019 | |
Rachel Duan
BRD | Director/Board Member | 57 | 27/04/2020 |
Lise Kingo
BRD | Director/Board Member | 65 | 27/04/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06/07/26 | Others | Executive/Senior Manager | 55,000 | 0.0045% | ||
| 15/11/25 | Buy | Director | 207 | 0.0000% | ||
| 29/07/25 | Buy | Director | 6 | 0.0000% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.15% | -6.78% | -9.18% | -20.68% | 103B | |
| +4.86% | -3.32% | +52.73% | +160.26% | 995B | |
| +1.04% | -2.99% | +50.87% | +52.38% | 614B | |
| +0.98% | -6.49% | +24.00% | +66.66% | 431B | |
| +1.96% | +0.83% | +42.80% | +37.60% | 353B | |
| -0.11% | -4.07% | +30.37% | +39.73% | 293B | |
| +2.52% | -8.36% | +7.27% | +10.32% | 245B | |
| +4.57% | +5.21% | +35.91% | +67.64% | 210B | |
| -4.32% | -12.94% | -3.79% | -44.56% | 210B | |
| -2.58% | -0.73% | +17.16% | +67.46% | 168B | |
| Average | +0.49% | -4.04% | +24.81% | +43.68% | 362.09B | |
| Weighted average by Cap. | +0.72% | -4.03% | +35.49% | +72.32% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 47.5B 54.85B 44.28B 40.73B 76.88B 5,215B 77.74B 520B 204B 2,609B 206B 201B 8,642B | 50.62B 58.45B 47.19B 43.4B 81.94B 5,558B 82.85B 555B 218B 2,781B 220B 215B 9,210B |
| Net income | 7.69B 8.88B 7.17B 6.59B 12.45B 844B 12.59B 84.26B 33.07B 423B 33.36B 32.62B 1,399B | 9.35B 10.8B 8.72B 8.02B 15.14B 1,027B 15.31B 102B 40.21B 514B 40.56B 39.66B 1,702B |
| Net Debt | 11.37B 13.12B 10.6B 9.75B 18.4B 1,248B 18.6B 125B 48.87B 624B 49.29B 48.21B 2,068B | 7.68B 8.86B 7.16B 6.58B 12.42B 843B 12.56B 84.09B 33B 422B 33.29B 32.55B 1,397B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/08/26 | €74.50 | +0.15% | 1,565,343 |
| 04/08/26 | €74.39 | -0.15% | 1,666,594 |
| 03/08/26 | €74.50 | +0.04% | 2,150,645 |
| 31/07/26 | €74.47 | +2.34% | 3,588,109 |
| 30/07/26 | €72.77 | -8.95% | 7,029,785 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- SAN Stock
Select your edition
All financial news and data tailored to specific country editions
